Identifying
therapeutic needs and providing solutions
In the present pharmaceutical R&D environment,
there is an increasing need to maximize
the value of existing active ingredients
(AIs) and products (chemical entities).
In addition, there have been reports of
negative clinical trial outcomes for new
AIs attributable poorly optimized formulations.
Specialty pharmaceutical companies are,
therefore, keen to avail services for product
reformulations and life cycle management
from competent development partners. Rubicon Research
has the insight into this complex, scientific
requirement, and the multidisciplinary skill
sets to offer solutions to these pharmaceutical
companies. Rubicon Research also has capability to
identify these needs upfront and provide
solutions that result in appropriate value
addition to both the partners.
|
|